L 691831

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596652

CAS#: 136668-70-7

Description: L 691831 is a radioiodinated inhibitor of leukotriene synthesis.


Chemical Structure

img
L 691831
CAS# 136668-70-7

Theoretical Analysis

MedKoo Cat#: 596652
Name: L 691831
CAS#: 136668-70-7
Chemical Formula: C36H38N2O4
Exact Mass: 562.28
Molecular Weight: 562.710
Elemental Analysis: C, 76.84; H, 6.81; N, 4.98; O, 11.37

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: L 691831; L-691831; L691831; L-691,831; L 691,831; L691,831;

IUPAC/Chemical Name: 3-(1-benzyl-3-(3,3-dimethylbutanoyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropanoic acid

InChi Key: APLNXIHARZQHIK-UHFFFAOYSA-N

InChi Code: InChI=1S/C36H38N2O4/c1-35(2,3)21-32(39)33-28-19-27(42-23-26-16-15-25-13-9-10-14-29(25)37-26)17-18-30(28)38(22-24-11-7-6-8-12-24)31(33)20-36(4,5)34(40)41/h6-19H,20-23H2,1-5H3,(H,40,41)

SMILES Code: O=C(O)C(C)(C)CC(N1CC2=CC=CC=C2)=C(C(CC(C)(C)C)=O)C3=C1C=CC(OCC4=NC5=CC=CC=C5C=C4)=C3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 562.71 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Macdonald D, Brideau C, Chan CC, Falgueyret JP, Frenette R, Guay J, Hutchinson JH, Perrier H, Prasit P, Riendeau D, Tagari P, Thérien M, Young RN, Girard Y. Substituted 2,2-bisaryl-bicycloheptanes as novel and potent inhibitors of 5-lipoxygenase activating protein. Bioorg Med Chem Lett. 2008 Mar 15;18(6):2023-7. doi: 10.1016/j.bmcl.2008.01.105. Epub 2008 Feb 2. PubMed PMID: 18276139.

2: Charleson S, Evans JF, Léger S, Perrier H, Prasit P, Wang Z, Vickers PJ. Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein. Eur J Pharmacol. 1994 May 17;267(3):275-80. PubMed PMID: 8088366.

3: Mancini JA, Coppolino MG, Klassen JH, Charleson S, Vickers PJ. The binding of leukotriene biosynthesis inhibitors to site-directed mutants of human 5-lipoxygenase-activating protein. Life Sci. 1994;54(9):PL137-42. PubMed PMID: 8114608.

4: Mancini JA, Abramovitz M, Cox ME, Wong E, Charleson S, Perrier H, Wang Z, Prasit P, Vickers PJ. 5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett. 1993 Mar 8;318(3):277-81. PubMed PMID: 8440384.

5: Charleson S, Prasit P, Léger S, Gillard JW, Vickers PJ, Mancini JA, Charleson P, Guay J, Ford-Hutchinson AW, Evans JF. Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition. Mol Pharmacol. 1992 May;41(5):873-9. PubMed PMID: 1588922.